This module allows you to analyze existing cross correlation between Alnylam Pharmaceuticals and Facebook. You can compare the effects of market volatilities on Alnylam Pharmaceuticals and Facebook and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Facebook. See also your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Facebook.
|Horizon||30 Days Login to change|
Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 30 days. Inspite fairly weak basic indicators, Alnylam Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in November 2019.
Over the last 30 days Facebook has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Facebook is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short term losses for the investors.
Alnylam Pharmaceuticals and Facebook Volatility Contrast
Predicted Return Density
Alnylam Pharmaceuticals Inc vs. Facebook Inc
Given the investment horizon of 30 days, Alnylam Pharmaceuticals is expected to generate 1.7 times more return on investment than Facebook. However, Alnylam Pharmaceuticals is 1.7 times more volatile than Facebook. It trades about 0.06 of its potential returns per unit of risk. Facebook is currently generating about -0.05 per unit of risk. If you would invest 7,589 in Alnylam Pharmaceuticals on September 16, 2019 and sell it today you would earn a total of 575.00 from holding Alnylam Pharmaceuticals or generate 7.58% return on investment over 30 days.
Pair Corralation between Alnylam Pharmaceuticals and Facebook
|Time Period||3 Months [change]|
Diversification Opportunities for Alnylam Pharmaceuticals and Facebook
Very good diversification
Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals Inc and Facebook Inc in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Facebook and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Facebook. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Facebook has no effect on the direction of Alnylam Pharmaceuticals i.e. Alnylam Pharmaceuticals and Facebook go up and down completely randomly.
See also your portfolio center. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..